Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Thompson

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
Trends in Pharmacological Sciences|February 6, 2013
Recent developments in 5-HT3 receptor pharmacologyAndrew J Thompson
Neuropharmacology|October 10, 2015
Lighting up neuroscienceAndrew J Thompson, Martin Lochner
Methods in Molecular Biology (Clifton, N.J.)|September 15, 2010
Protocol for quantitative proteomics of cellular membranes and membrane raftsAndrew J Thompson, Ritchie Williamson
Neuropharmacology|April 21, 2015
A review of fluorescent ligands for studying 5-HT3 receptorsMartin Lochner, Andrew J Thompson
Neuropharmacology|April 26, 2016
The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT3 receptorsMartin Lochner, Andrew J Thompson
The Journal of Pharmacology and Experimental Therapeutics|October 4, 2014
The antimalarial drug proguanil is an antagonist at 5-HT3 receptorsMartin Lochner, Andrew J Thompson
Current Medicinal Chemistry|October 9, 2002
Protein conformational misfolding and amyloid formation: characteristics of a new class of disorders that include Alzheimer's and Prion diseasesAndrew J Thompson, Colin J Barrow
Scientific Reports|December 15, 2019
Evidence for an effect of receptor density on ligand occupancy and agonist EC<sub>50</sub>Gavin E Jarvis, Andrew J Thompson
Trends in Pharmacological Sciences|August 27, 2013
A golden approach to ion channel inhibitionGavin E Jarvis, Andrew J Thompson
The Journal of Biological Chemistry|November 4, 2020
Adaptation of influenza viruses to human airway receptorsAndrew J Thompson, James C Paulson
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
Trends in Pharmacological Sciences|February 6, 2013
Recent developments in 5-HT3 receptor pharmacologyAndrew J Thompson
Neuropharmacology|October 10, 2015
Lighting up neuroscienceAndrew J Thompson, Martin Lochner
Methods in Molecular Biology (Clifton, N.J.)|September 15, 2010
Protocol for quantitative proteomics of cellular membranes and membrane raftsAndrew J Thompson, Ritchie Williamson
Neuropharmacology|April 21, 2015
A review of fluorescent ligands for studying 5-HT3 receptorsMartin Lochner, Andrew J Thompson
Neuropharmacology|April 26, 2016
The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT3 receptorsMartin Lochner, Andrew J Thompson
The Journal of Pharmacology and Experimental Therapeutics|October 4, 2014
The antimalarial drug proguanil is an antagonist at 5-HT3 receptorsMartin Lochner, Andrew J Thompson
Current Medicinal Chemistry|October 9, 2002
Protein conformational misfolding and amyloid formation: characteristics of a new class of disorders that include Alzheimer's and Prion diseasesAndrew J Thompson, Colin J Barrow
Scientific Reports|December 15, 2019
Evidence for an effect of receptor density on ligand occupancy and agonist EC<sub>50</sub>Gavin E Jarvis, Andrew J Thompson
Trends in Pharmacological Sciences|August 27, 2013
A golden approach to ion channel inhibitionGavin E Jarvis, Andrew J Thompson
The Journal of Biological Chemistry|November 4, 2020
Adaptation of influenza viruses to human airway receptorsAndrew J Thompson, James C Paulson
Pageof 17